66 results on '"Bentzen, Soren"'
Search Results
2. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer
3. Early lesion-specific 18F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer
4. Changes in pulmonary function after definitive radiotherapy for NSCLC
5. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake
6. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity
7. STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics
8. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction
9. Time evolution of regional CT density changes in normal lung after IMRT for NSCLC
10. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity
11. Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review
12. Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: An exploratory study
13. Radiation dose response of normal lung assessed by Cone Beam CT – A potential tool for biologically adaptive radiation therapy
14. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: Safety profile for RTOG 0933
15. A systematic methodology review of phase I radiation dose escalation trials
16. Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study
17. A modelling study of the potential influence of low dose hypersensitivity on radiation treatment planning
18. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response
19. Influence of connective tissue diseases on the expression of radiation side effects: A systematic review
20. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project
21. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
22. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study
23. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial
24. Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas
25. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary
26. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation
27. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
28. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial
29. Clinical radiation doses for spinal cord: the 1998 international questionnaire
30. Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial
31. Conducting radiogenomic research – Do not forget careful consideration of the clinical data
32. Randomized controlled trials in health technology assessment: Overkill or overdue?
33. The α/β ratio for prostate cancer: What is it, really?
34. Equieffective dose and bioeffect modeling – In reply to Dr. Fowler
35. Literature-based analysis of preoperative chemoradiotherapy in oesophageal cancer: In response to Srinivas et al.
36. Radiation therapy: Intensity modulated, image guided, biologically optimized and evidence based
37. REPLY TO LETTER TO THE EDITOR, REGARDING OUR PAPER “INTERNATIONAL CONSENSUS ON PALLIATIVE RADIOTHERAPY ENDPOINTS FOR FUTURE CLINICAL TRIALS IN BONE METASTASES”
38. Late morbidity: the Damocles Sword of radiotherapy?
39. ACCELERATED RADIOTHERAPY VS. CHEMORADIATION IN NON-SMALL CELL LUNG CANCER: QUANTIFYING THE HAZARDS
40. UPDATED DATA FOR CHART IN NSCLC: FURTHER ANALYSES
41. Radiobiological considerations in the design of clinical trials
42. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis
43. Clinical evidence for tumor clonogen regeneration: interpretations of the data
44. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study
45. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy
46. Rates of local control, metastasis, and overall survival in patients with posterior uveal melanomas treated with ruthenium-106 plaques
47. Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system
48. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases
49. Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy
50. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.